Condition: Chronic Pain · Low Back Pain · Sponsor: Eli Lilly and Company
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Central Research Associates | Birmingham, Alabama, United States | — |
| Synexus Clinical Research US, Inc. | Phoenix, Arizona, United States | — |
| Arizona Research Center | Phoenix, Arizona, United States | — |
| Desert Oasis Healthcare Medical Group | Palm Springs, California, United States | — |
| Artemis Institute for Clinical Research | Riverside, California, United States | — |
| Artemis Institute for Clinical Research | San Diego, California, United States | — |
| CMR of Greater New Haven | Hamden, Connecticut, United States | — |
| Bradenton Research Center, Inc. | Bradenton, Florida, United States | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand, Florida, United States | — |
| K2 MEDICAL Research THE VILLAGES | Lady Lake, Florida, United States | — |
| K2 Medical Research ORLANDO | Maitland, Florida, United States | — |
| Merritt Island Medical Research, LLC | Merritt Island, Florida, United States | — |
+ 25 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.